Clinical trial
D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to…
NCT00047476 · Celgene Corporation, Industry · Completed
Key facts
| NCT number | NCT00047476 |
|---|---|
| Title | D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients |
| Official title | Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of d-MPH in the Treatment of Fatigue and Neurobehavioral Impairment Related to Chemotherapy in Adult Cancer Patients |
| Lead sponsor | Celgene Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fatigue, Neoplasms |
| Intervention type | Drug |
| Interventions | dexmethylphenidate(d-mph) |
| Enrollment | 160 |
| Start date | Jun 1, 2002 |
| Completion | Mar 1, 2004 |
| First posted | Oct 9, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: